Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-04-10
2010-02-09
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S269000, C514S275000, C544S122000, C544S298000, C544S330000
Reexamination Certificate
active
07659271
ABSTRACT:
A compound represented by the following general formula (I), wherein R1, R2, R3, R4and R5represent hydrogen atom, a halo(lower alkyl) group, cyano group and the like, R6represents an alkyl group, a cycloalkyl group and the like, R7, R8, R9and R10represent hydrogen atom, a halogen atom, a lower alkyl group, a halo(lower alkyl) group and the like, R11and R12represent hydrogen atom, a lower alkyl group, a (lower cycloalkyl) (lower alkyl) group and the like, and R13represents hydrogen atom, a halogen atom, a lower alkoxy group and the like, which has potent inhibitory activity on cholesterol ester transfer protein (CETP).
REFERENCES:
patent: 6426365 (2002-07-01), Shinkai et al.
patent: 2005/0059810 (2005-03-01), Maeda et al.
patent: 2006/0178514 (2006-08-01), Baruah et al.
patent: 2006/0270705 (2006-11-01), Yonemori et al.
patent: 2007/0015758 (2007-01-01), Baruah et al.
patent: 2009/0023729 (2009-01-01), Nakamura et al.
patent: 2009/0029994 (2009-01-01), Nakamura et al.
patent: 2009/0054474 (2009-02-01), Ohgiya et al.
patent: 2009/0062306 (2009-03-01), Ohgiya et al.
patent: 1 020 439 (2000-07-01), None
patent: 11-49743 (1999-02-01), None
patent: 2003-221376 (2003-08-01), None
patent: 98/35937 (1998-08-01), None
patent: 00/17164 (2000-03-01), None
patent: 00/17165 (2000-03-01), None
patent: 00/17166 (2000-03-01), None
patent: 03/063868 (2003-08-01), None
patent: 2004/020393 (2004-03-01), None
patent: 2005/095395 (2005-10-01), None
patent: 2006/056854 (2006-06-01), None
patent: 2006/073973 (2006-07-01), None
patent: 2006/098394 (2006-09-01), None
patent: 2007/041494 (2007-04-01), None
patent: 2007/073934 (2007-07-01), None
patent: 2007/075194 (2007-07-01), None
patent: 2007/088996 (2007-08-01), None
patent: 2007/088999 (2007-08-01), None
patent: 2007/126043 (2007-11-01), None
patent: 2007/128568 (2007-11-01), None
patent: 2008/018529 (2008-02-01), None
Vippagunta et al., Crystalline Solids, Advanced Drug Delivery Reviews, 48, pp. 3-26, 2001.
West, Solid Solutions, Solid State Chemistry and its applications, pp. 358 & 365, 1988.
Ulrich, Chapter 4: Crystallization, Kirk-Othmer Encyclopedia of Chemical Technology, Aug. 2002.
English Language Abstract of JP 11-49743.
de Grooth, G.J. et al. Efficacy and Safety of a Novel Cholesteryl Ester Transfer Protein Inhibitor, JTT-705, in Humans,Circulation, vol. 105, No. 18, pp. 2159-2165 (2002).
Usui et al., “A New On-line Dual Enzymatic Method for Simultaneous Quantification of Cholesterol and Triglycerides in Lipoproteins by HPLC,” Journal of Lipid Research, vol. 43, pp. 805-814 (2002).
English Language Abstract of JP 2003-221376.
U.S. Appl. No. 11/835,127 to Ohgiya et al., entitled “Novel Pyrimidine Compounds Having Benzyl(Pyridylmethyl)Amine-Strucute and Medicament Comprising the Same,” filed on Aug. 7, 2007.
U.S. Appl. No. 12/045,982 to Ohgiya et al., entitled “Novel Pyrimidine Compound Having Benzyl (Heterocyclylmethyl)Amine Structure and Medicament Comprising the Same;” filed on Mar. 11, 2008.
Gomtsyan et al., Bioorganic & Medicinal Chemistry Letters, 2007, vol. 17, pp. 3894-3899.
H. Takahashi et al., Bioorganic & Medicinal Chemistry Letters, 2007, vol. 17, pp. 5091-5095.
Aoki Taro
Arai Toshiharu
Miura Toru
Miyosawa Katsutoshi
Ohgiya Tadaaki
Greenblum & Bernstein P.L.C.
Kowa Company Ltd.
Rao Deepak
LandOfFree
Pyrimidine compound having dibenzylamine structure and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidine compound having dibenzylamine structure and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine compound having dibenzylamine structure and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4224380